Detection of a CYP3A5 allelic variant: A candidate for the polymorphic expression of the protein?

被引:74
作者
Jounaidi, Y [1 ]
Hyrailles, V [1 ]
Gervot, L [1 ]
Maurel, P [1 ]
机构
[1] CNRS,INSERM,U128,F-34033 MONTPELLIER,FRANCE
关键词
D O I
10.1006/bbrc.1996.0618
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In liver samples from 19 Caucasian subjects, the CYP3A5 protein was detected in 74% of individuals (14/19), while the messenger was shown to be expressed in 100% of individuals, assessed by the RT-PCR method. In order to characterise the putative mutation(s) in the messenger, accounting for the absence of protein accumulation, the full coding region of the CYP3A5 cDNA was sequenced for two unrelated individuals, one expressing the protein at a high level and one being defective. A point mutation in exon 11 at position 1280 (C-->A) was found to cosegregate with the absence of protein accumulation in 2 of the 5 defective individuals. This mutation produces a change in the aminoacid at position 398 (Thr-->Asn). Whether this mutation affects the stability of the protein or whether it is in linkage desequilibrium with other mutation(s) in the non-coding region of the messenger is not known. The C-->A change at 1280 generates a Tsp509 I site which can be used for routine evaluation of the frequency of this mutation in population studies. (C) 1996 Academic Press, Inc.
引用
收藏
页码:466 / 470
页数:5
相关论文
共 19 条
  • [1] AOYAMA T, 1989, J BIOL CHEM, V264, P10388
  • [2] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [3] DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387
  • [4] HUMAN P450PCN1 - SEQUENCE, CHROMOSOME LOCALIZATION, AND DIRECT EVIDENCE THROUGH CDNA EXPRESSION THAT P450PCN1 IS NIFEDIPINE OXIDASE
    GONZALEZ, FJ
    SCHMID, BJ
    UMENO, M
    MCBRIDE, OW
    HARDWICK, JP
    MEYER, UA
    GELBOIN, HV
    IDLE, JR
    [J]. DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1988, 7 (02): : 79 - 86
  • [5] MOLECULAR-GENETICS OF THE P-450 SUPERFAMILY
    GONZALEZ, FJ
    [J]. PHARMACOLOGY & THERAPEUTICS, 1990, 45 (01) : 1 - 38
  • [6] PURIFICATION AND PROPERTIES OF CYTOCHROME-P-450 FROM HOMOGENATES OF HUMAN-FETAL LIVERS
    KITADA, M
    KAMATAKI, T
    ITAHASHI, K
    RIKIHISA, T
    KATO, R
    KANAKUBO, Y
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 241 (01) : 275 - 280
  • [7] IDENTIFICATION OF RIFAMPIN-INDUCIBLE P450IIIA4 (CYP3A4) IN HUMAN SMALL-BOWEL ENTEROCYTES
    KOLARS, JC
    SCHMIEDLINREN, P
    SCHUETZ, JD
    FANG, C
    WATKINS, PB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 1871 - 1878
  • [8] MOLECULAR-CLONING AND SEQUENCE-ANALYSIS OF CDNA CONTAINING THE ENTIRE CODING REGION FOR HUMAN-FETAL LIVER CYTOCHROME-P-450
    KOMORI, M
    NISHIO, K
    OHI, H
    KITADA, M
    KAMATAKI, T
    [J]. JOURNAL OF BIOCHEMISTRY, 1989, 105 (02) : 161 - 163
  • [9] LOWN KS, 1994, DRUG METAB DISPOS, V22, P947
  • [10] MAUREL P, 1996, CYTOCHROMES P450 MET